Community Clinical Oncology Program

社区临床肿瘤学计划

• 批准号: 7845052
• 负责人: David L Grinblatt
• 金额: $ 29.46万
• 依托单位: NORTHSHORE UNIVERSITY HEALTHSYSTEM
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-01 至 2013-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7845052
• 关键词: Area; Arts; Breast; Cancer Survivorship; Catchment Area; Chest; Chicago; Clinical; Clinical Research; Clinical Trials; Communities; Community Clinical Oncology Program; Controlled Study; County; Goals; Health Promotion and Education; Healthcare; Illinois; Institution; Leadership; Medical; Population; Positioning Attribute; Prevention; Quality of life; Research; Underrepresented Minority; base; cancer genetics; cancer therapy; clinical practice; experience; meetings; neuro-oncology; oncology; programs; suburb; tertiary care

Description (provided by applicant): Evanston Northwestern Healthcare has over 20 years of successful participation as an NCI-designated CCOP. Over these years we have met or exceeded clinical trial accrual goals, held leadership positions in our research bases, directed national cooperative group studies and brought to the cooperative groups our experience and expertise in many areas such as quality-of-life research, cancer survivorship, thoracic and breast oncology, neuro-oncology and cancer genetics. Evanston Northwestern Healthcare has the only tertiary care oncology program in our area (population >1.2 million) with consistent participation in NCI-approved cancer treatment, prevention and control studies. We are the major supplier of oncologic healthcare in our area, and a major force for health education and promotion. The specific aims of this renewal proposal are: 1 To continue to offer the populations of the North suburbs of Chicago state-of-the-art clinical research trials covering cancer treatment, control, and prevention. 2. To extend our efforts into Lake County, Illinois (population 713,000), one of the fastest growing communities in the Midwest and until now not served by any medical institution with consistent participation in NIH-approved clinical trials in oncology. 3. To disseminate within our catchment area state-of-the-art clinical practice in oncology as an outgrowth of our participation in the CCOP programs. 4. To bring to our national research bases expertise and proposals based on the ongoing research programs and clinical strengths of Evanston Northwestern Healthcare, and reflecting the needs of our community. 5. To expand our cancer treatment, prevention and control efforts to underserved and minority populations. 6. To continue our leadership positions in our established national research bases and to offer leadership in our new research base.

描述（由申请人提供）： Evanston Northwestern Healthcare作为NCI指定的CCOP成功参与了20多年。这些年来，我们达到或超过了临床试验的应计目标，在我们的研究基础上担任领导职务，指导国家合作小组研究，并将我们在许多领域的经验和专业知识带给了我们的经验和专业知识，例如生活质量研究，癌症幸存，胸腔和乳腺癌学和乳房肿瘤学，神经元学和癌症学和癌症遗传学。 埃文斯顿西北医疗保健公司（Evanston Northwestern Healthcare）拥有我们地区唯一的三级护理肿瘤计划（人口> 120万），持续参与NCI批准的癌症治疗，预防和对照研究。我们是我们地区肿瘤保健的主要供应商，也是健康教育和晋升的主要力量。 该更新建议的具体目的是： 1继续提供芝加哥最先进的临床研究试验的北部郊区，涉及癌症治疗，控制和预防。 2。将我们的努力扩展到伊利诺伊州的莱克县（人口713,000），这是中西部增长最快的社区之一，直到现在，直到现在，任何医疗机构都没有为NIH批准的肿瘤学临床试验提供一贯的参与。 3。要在我们的集水区域内传播肿瘤学的最先进的临床实践，这是我们参与CCOP计划的产物。 4.为了基于埃文斯顿西北医疗保健的持续研究计划和临床优势，将我们的国家研究基础提出了专业知识和建议，并反映了我们社区的需求。 5。将我们的癌症治疗，预防和控制工作扩大到服务不足和少数群体。 6。在我们既定的国家研究基础上继续我们的领导职务，并在我们的新研究基础上提供领导地位。